A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
Stopped 42847922MDD3002 was stopped based on the interim analysis (IA) results as recommended by the Independent Data Monitoring Committee (IDMC)
Conditions
- Depressive Disorder, Major
Interventions
- DRUG: Seltorexant
- DRUG: Placebo
Sponsor
Janssen Research & Development, LLC